GS1-144 in Participants With Hepatic Impairment and Healthy Female

NCT07491289 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment and Healthy Female

Interventions

DRUG: GS1-144 tablet

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.